43 related articles for article (PubMed ID: 11889348)
1. Attention-Deficit/Hyperactivity Disorder.
Banaschewski T; Becker K; Döpfner M; Holtmann M; Rösler M; Romanos M
Dtsch Arztebl Int; 2017 Mar; 114(9):149-159. PubMed ID: 28351467
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of Psychotropic Medications in Children with Prenatal Alcohol and Drug Exposures: A Case Series and Model of Care.
Ritfeld GJ; Kable JA; Holton JE; Coles CD
Child Psychiatry Hum Dev; 2024 Jun; 55(3):744-753. PubMed ID: 36183050
[TBL] [Abstract][Full Text] [Related]
3. Media portrayals of psychotropic agents in AD/HD treatment: A social constructionist approach.
Qaderi J; Lindblom J
Health (London); 2024 May; 28(3):431-449. PubMed ID: 37077030
[TBL] [Abstract][Full Text] [Related]
4. The Black Book of Psychotropic Dosing and Monitoring.
Schatzberg AF; Charles D
Psychopharmacol Bull; 2018 Jan; 48(1):64-153. PubMed ID: 29382960
[No Abstract] [Full Text] [Related]
5. Physician Care Coordination and the Use of Psychotropic Polypharmacy in the Management of Pediatric Mental Disorders.
Medhekar R; Fujimoto K; Aparasu RR; Bhatara VS; Johnson ML; Alonzo JP; Schwarzwald HL; Chen H
J Manag Care Spec Pharm; 2019 Jan; 25(1):29-38. PubMed ID: 30589632
[TBL] [Abstract][Full Text] [Related]
6. Predictors of polypharmacy and off-label prescribing of psychotropic medications: a national survey of child and adolescent psychiatrists.
Kearns MA; Hawley KM
J Psychiatr Pract; 2014 Nov; 20(6):438-47. PubMed ID: 25406048
[TBL] [Abstract][Full Text] [Related]
7. Assessment of attention in preschoolers.
Mahone EM; Schneider HE
Neuropsychol Rev; 2012 Dec; 22(4):361-83. PubMed ID: 23090646
[TBL] [Abstract][Full Text] [Related]
8. Pediatric psychotropic polypharmacy.
Zonfrillo MR; Penn JV; Leonard HL
Psychiatry (Edgmont); 2005 Aug; 2(8):14-9. PubMed ID: 21152168
[TBL] [Abstract][Full Text] [Related]
9. Multiple psychiatric diagnoses common in privately insured children on atypical antipsychotics.
Halloran DR; Swindle J; Takemoto SK; Schnitzler MA
Clin Pediatr (Phila); 2010 May; 49(5):485-90. PubMed ID: 20118088
[TBL] [Abstract][Full Text] [Related]
10. Prospective, naturalistic, pilot study of open-label atomoxetine treatment in preschool children with attention-deficit/hyperactivity disorder.
Ghuman JK; Aman MG; Ghuman HS; Reichenbacher T; Gelenberg A; Wright R; Rice S; Fort C
J Child Adolesc Psychopharmacol; 2009 Apr; 19(2):155-66. PubMed ID: 19364293
[TBL] [Abstract][Full Text] [Related]
11. Rise in psychotropic drug prescribing in children and adolescents during 1992-2001: a population-based study in the UK.
Hsia Y; Maclennan K
Eur J Epidemiol; 2009; 24(4):211-6. PubMed ID: 19266290
[TBL] [Abstract][Full Text] [Related]
12. Preschool parent-pediatrician consultations and predictive referral patterns for problematic behaviors.
Fanton JH; MacDonald B; Harvey EA
J Dev Behav Pediatr; 2008 Dec; 29(6):475-82. PubMed ID: 18941427
[TBL] [Abstract][Full Text] [Related]
13. Psychopharmacological and other treatments in preschool children with attention-deficit/hyperactivity disorder: current evidence and practice.
Ghuman JK; Arnold LE; Anthony BJ
J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):413-47. PubMed ID: 18844482
[TBL] [Abstract][Full Text] [Related]
14. The QT interval and psychotropic medications in children: recommendations for clinicians.
McNally P; McNicholas F; Oslizlok P
Eur Child Adolesc Psychiatry; 2007 Feb; 16(1):33-47. PubMed ID: 16944043
[TBL] [Abstract][Full Text] [Related]
15. Children's mental health services in fee-for-service Medicaid.
Larson MJ; Miller K; Sharma S; Manderscheid R
Health Care Financ Rev; 2004; 26(1):5-22. PubMed ID: 15776697
[TBL] [Abstract][Full Text] [Related]
16. Patterns of psychotropic medication use in very young children with attention-deficit hyperactivity disorder.
Rappley MD; Eneli IU; Mullan PB; Alvarez FJ; Wang J; Luo Z; Gardiner JC
J Dev Behav Pediatr; 2002 Feb; 23(1):23-30. PubMed ID: 11889348
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of attention-deficit/hyperactivity disorder and use of psychotropic medication in very young children.
Rappley MD; Mullan PB; Alvarez FJ; Eneli IU; Wang J; Gardiner JC
Arch Pediatr Adolesc Med; 1999 Oct; 153(10):1039-45. PubMed ID: 10520611
[TBL] [Abstract][Full Text] [Related]
18. Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder.
Guevara J; Lozano P; Wickizer T; Mell L; Gephart H
Pediatrics; 2002 May; 109(5):733-9. PubMed ID: 11986429
[TBL] [Abstract][Full Text] [Related]
19. Medication patterns for attention-deficit/hyperactivity disorder and comorbid psychiatric conditions in a low-income population.
Radigan M; Lannon P; Roohan P; Gesten F
J Child Adolesc Psychopharmacol; 2005 Feb; 15(1):44-56. PubMed ID: 15741785
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
